StonvexLoading…
StonvexStonvexStonvexCore line items from ACCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 |
|---|---|---|---|
Revenue | $4.89M | $4.37M | $3.70M |
Operating Income | $1.08M | $1.06M | $482.22K |
Net Income | $1.02M | $992.83K | $641.85K |
EPS (Diluted) | $0.08 | $0.08 | $0.05 |
Total Assets | $3.91M | $2.68M | Not available |
Total Liabilities | $1.72M | $1.53M | Not available |
Cash & Equivalents | $2.45M | $1.12M | $1.80M |
Free Cash Flow OCF − CapEx | $1.51M | $1.12M | $734.32K |
Shares Outstanding | 12.50M | 12.50M | 12.50M |